澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

醫藥生物股

592.490

+0.4710.08%

漲家數：14

跌家數：14

平家數：17

市盈率：- -

高：597.258

開：593.703

低：587.469

收：592.019

成交量：9,170.12萬

成交額：1.71億

市值：813.85億

流通市值：783.98億

資料載入中...

總覽新聞資訊

Mesoblast公布上半年總收入5130萬美元

Mesoblast Limited預計2026財年Ryoncil淨收入將達1.1億至1.2億美元

IMMURON LTD作出戰略決策：尋求合作伙伴為Travelan與IMM-529臨床項目提供資金支持

Mayne製藥集團——將繼續推進產品組合規模化戰略，可能包含股票回購計劃

重發-澳大利亞股市攀升，NAB 股價創下新高，BlueScope 因出價提高而跳漲

BUZZ-澳大利亞 CSL 公司與禮來公司簽署許可協議後恢復元氣

CSL有限公司簽署獨家許可協議獲Clazakizumab開發及商業化特定權利

Botanix製藥公司獲得4000萬澳元兩輪增發堅定承諾，新股發行價每股0.06澳元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK7508/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK7508","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"醫藥生物股","latestPrice":592.4896,"timestamp":1772168399911,"preClose":592.0187,"halted":0,"volume":91701236,"delay":0,"changeRate":0.000795,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":0.470947,"latestTime":"02-27 16:00:00 AEDT","open":593.7034,"high":597.2581,"low":587.4691,"amount":170861640,"amplitude":0.016535,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1772406000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1772146800000,1772168400000]],"turnoverRate":0.003522,"increases":13,"decrements":14,"flats":17,"marketCap":81385318361.75,"floatMarketCap":78397802434.75},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK7508\",,,,,undefined,":{"symbol":"BK7508","high":597.2581,"amplitude":0.016535,"preClose":592.0187,"low":587.4691,"latestPrice":592.4896,"volume":91701236,"delay":0,"open":593.7034,"prevYearClose":644.3692,"prevWeekClose":619.951,"prevMonthClose":674.161,"prevQuarterClose":644.369,"fiveDayClose":619.951,"twentyDayClose":674.161,"sixtyDayClose":670.922,"secType":"PLATE","market":"AU","turnoverRate":0.003522,"marketCap":81385318361.75,"floatMarketCap":78397802434.75,"timestamp":1772168399911,"nameCN":"醫藥生物股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK7508\",,,,undefined,":{"bkCode":"BK7508","up":14,"down":14,"flat":17},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK7508\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1171017622","title":"Mesoblast公布上半年總收入5130萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1171017622","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171017622?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 10:15","pubTimestamp":1772158552,"startTime":"0","endTime":"0","summary":"2月27日（路透社）—— Mesoblast Ltd 发布中期业绩公告：*上半年总收入达5130万美元* *归属于公司亏损为4020万美元*\n更多公司相关报道可参考股票代码MSB.AX。\n（信息来源：路透社简报；发布时间：2026年2月27日02:03:10 GMT）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MSB.AU","BK7508","BK7501","BK7067"],"gpt_icon":0},{"id":"1110626132","title":"Mesoblast Limited預計2026財年Ryoncil淨收入將達1.1億至1.2億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1110626132","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110626132?lang=zh_tw&edition=fundamental","pubTime":"2026-02-27 05:53","pubTimestamp":1772142784,"startTime":"0","endTime":"0","summary":"生物技术企业Mesoblast Limited最新预测显示，其核心产品Ryoncil在2026财年的全年净收入预计将介于1.1亿美元至1.2亿美元之间。这一预期反映了公司对产品商业化前景的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MESO","BK7501","MSB.AU","BK7508","BK4139","BK7067"],"gpt_icon":0},{"id":"1138357123","title":"IMMURON LTD作出戰略決策：尋求合作伙伴為Travelan與IMM-529臨床項目提供資金支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1138357123","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138357123?lang=zh_tw&edition=fundamental","pubTime":"2026-02-25 19:12","pubTimestamp":1772017927,"startTime":"0","endTime":"0","summary":"IMMURON LTD宣布已制定关键战略方针，将通过寻求外部合作的方式为旗下两款核心产品——Travelan与IMM-529的临床研究计划注入资金动力。该决策旨在加速推进两项临床项目的研发进程，同时优化公司资源分配结构。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMC.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"1174229185","title":"Mayne製藥集團——將繼續推進產品組合規模化戰略，可能包含股票回購計劃","url":"https://stock-news.laohu8.com/highlight/detail?id=1174229185","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174229185?lang=zh_tw&edition=fundamental","pubTime":"2026-02-23 06:38","pubTimestamp":1771799894,"startTime":"0","endTime":"0","summary":"Mayne制药集团宣布将持续推进其产品组合的规模化战略，并透露未来可能采取包括股票回购在内的多元化举措。这一战略方向旨在优化公司资本结构并提升股东价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","MYX.AU","BK7508"],"gpt_icon":0},{"id":"2612494795","title":"重發-澳大利亞股市攀升，NAB 股價創下新高，BlueScope 因出價提高而跳漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2612494795","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612494795?lang=zh_tw&edition=fundamental","pubTime":"2026-02-18 09:37","pubTimestamp":1771378648,"startTime":"0","endTime":"0","summary":"更新版 1-重发-澳大利亚股市攀升，NAB 股价创下新高，BlueScope 因出价提高而跳涨更新新西兰央行政策决定和修正后的股价。路透2月18日 - 澳大利亚股市周三攀升，澳洲国民银行在公布强劲的第一季度数据后创下历史新高，而博思格钢铁公司因收购要约得到改善而跳涨。回到悉尼，澳洲国民银行NAB.AX的股价飙升5.8%，创下历史新高，此前该 ，在其业务和房屋贷款部门强劲表现的推动下，第一季度现金盈利增长16%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nL4T3ZE043:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015945.SGD","LU0323591593.USD","IE0009355771.USD","LU0708995401.HKD","LU2237443622.USD","SG9999015986.USD","IE0002141913.USD","LU1629891620.HKD","IE00B2B36J28.USD","LU0097036916.USD","SG9999001176.SGD","SG9999014880.SGD","SG9999014898.SGD","LU0114720955.EUR","SG9999017495.SGD","LLYX","LU1720051017.SGD","BK7511","SG9999013999.USD","SGXZ57979304.SGD","BK4534","LU2361044865.SGD","IE00BJLML261.HKD","LU0109394709.USD","LU0471298694.HKD","LU1323610961.USD","SGXZ31699556.SGD","IE0004445015.USD","LU0432979614.USD","LU1023059063.AUD","LU2089284900.SGD","LU1127390331.HKD","LU0320765992.SGD","IE00B7KXQ091.USD","LU2168564222.USD","LU0203202063.USD","LU2168564149.EUR","LU2552382132.HKD","LU0689472784.USD","IE00B775H168.HKD","LU0456855351.SGD","LU1035775433.USD","NAB.AU","BK7501","LU0234572021.USD","LU1814569148.SGD","LU0882574055.USD","IE00B1BXHZ80.USD","LU0889565916.HKD","LU0109391861.USD","LU2552382058.USD","IE00BFSS7M15.SGD","LU0943347566.SGD","LU2063271972.USD","LU0683600562.USD","LU1804176565.USD","LU0466842654.USD","LU2111349929.HKD","LU1974910355.USD","LU2491050071.SGD","LU2756315664.SGD","IE00BJJMRZ35.SGD","IE00B4JS1V06.HKD","IE00BK4W5M84.HKD","SG9999018857.SGD","LU0158827781.USD","SG9999001176.USD","BK7508","LU2237443978.SGD","IE0004445239.USD","IE00BJJMRY28.SGD","LU2361045086.USD","BK4585","LU2264538146.SGD","LU2087625088.SGD","LU2237438978.USD","LU1093756325.SGD","LU2089283258.USD","LU2750360997.AUD","LU2471134879.HKD","LU2471134952.CNY","LU2237443382.USD","LU0256863902.USD","LU0385154629.USD","LU0820561909.HKD","LU0006306889.USD","BK4516","LU0058720904.USD","LU2471134796.USD","LU1917777945.USD","LU0094547139.USD","LU1551013425.SGD","LU0122379950.USD","LU0096364046.USD","LU2237443465.HKD","IE00BJJMRX11.SGD","LU2746668461.USD","LU2756315318.SGD","LU0882574139.USD","LU2023250330.USD","BK7031","LU2896262040.SGD","LU0354030511.USD","BK4006","BK7135","ELIL","LU2213496289.HKD","LU2106854487.HKD","LU0823434740.USD","IE00B4R5TH58.HKD","LU2168564065.EUR","LU1232071149.USD","SGXZ81514606.USD","BK7034","LU1061106388.HKD","IE00B1XK9C88.USD","LU0640476718.USD","SG9999018865.SGD","LU1983299246.USD","SG9999015952.SGD","LU0672654240.SGD","IE00BK4W5L77.USD","LU2089984988.USD","LU2491049909.HKD","BK7120","LU0238689110.USD","LU2552382215.SGD","LU0210536198.USD","BSL.AU","LU1623119135.USD","LU2108987350.USD","LU2417539215.USD","IE00BJT1NW94.SGD","LU0964807845.USD","SG9999015978.USD","LU2265009873.SGD","LU1868837300.USD","LU2236285917.USD","LU1093756168.USD","LU0786609619.USD","LU0868494617.USD","LU2468319806.SGD","BK7129","LU0203201768.USD","BK4533","LU2456880835.USD","LU1868837136.USD","IE00BKDWB100.SGD","LLYZ","IE0005OL40V9.USD","BK4588","LU1291159041.SGD","LU1868836591.USD","SG9999014914.USD","IE00BWXC8680.SGD","LU2237443549.SGD","LU2211815571.USD","LU0353189763.USD","LU2023250504.SGD","LU1548497426.USD","LU2357305700.SGD","LU1267930730.SGD","IE00BKPKM429.USD","LU1064131342.USD","BK4581","LU0289739699.SGD","LU1145028129.USD","LU1868836914.USD","LU0823416689.USD","LU0266013472.USD","IE00BN29S564.USD","LU1989771016.USD","LU2461242641.AUD","LU0316494557.USD","LU2491050154.USD","LU0820562030.AUD","LU2023251221.USD","LU2237443895.HKD","LU2324357040.USD","LU2271345857.HKD","LU0353189680.USD","LU0079474960.USD","LU0158827948.USD","SGXZ51526630.SGD","SGXZ99366536.SGD","LU0820561818.USD","LU2462157665.USD","LU2361044949.HKD","LU0417517546.SGD","LU2028103732.USD","LU2168563687.JPY","LU0787776722.HKD","LU1069344957.HKD","LU1868836757.USD","LU0823434583.USD","LU2360106947.USD","IE00BFTCPJ56.SGD","LU0061475181.USD","LU0225283273.USD","LU2750360641.GBP","BK4599","LU0320765059.SGD","LU1712237335.SGD","LU1720051108.HKD","LU0198837287.USD","LU1057294990.SGD","LU1280957306.USD","LU2746668974.SGD","LU2602419157.SGD","LU1366192091.USD","LU2112291526.USD","LU2471134523.USD","GB00BDT5M118.USD","LU1988902786.USD","LU0106261372.USD","ELIS","LU1551013342.USD","LU2168564495.EUR","BK4007","BK7067","IE00BFSS8Q28.SGD","LU0256863811.USD","SG9999014906.USD","LU0354030438.USD","LU0471298777.SGD"],"gpt_icon":0},{"id":"2612129491","title":"BUZZ-澳大利亞 CSL 公司與禮來公司簽署許可協議後恢復元氣","url":"https://stock-news.laohu8.com/highlight/detail?id=2612129491","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612129491?lang=zh_tw&edition=fundamental","pubTime":"2026-02-18 08:32","pubTimestamp":1771374777,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nL4S3ZE01B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0471298694.HKD","LU2237443895.HKD","LU0353189680.USD","LU2168564149.EUR","LU0266013472.USD","LU2023250330.USD","LU2471134796.USD","LU0106261372.USD","LU2471134879.HKD","SG9999017495.SGD","SG9999015952.SGD","LU1061106388.HKD","SG9999014906.USD","LU0787776722.HKD","IE0004445239.USD","SGXZ31699556.SGD","LU0354030438.USD","LU1291159041.SGD","LU1323610961.USD","LU0203202063.USD","LU0094547139.USD","LU2271345857.HKD","LU0061475181.USD","LU1064131342.USD","BK7067","LU0289739699.SGD","IE00BK4W5M84.HKD","LU0471298777.SGD","LU0456855351.SGD","LU1868836757.USD","LU2756315664.SGD","LU0158827948.USD","LU2491050154.USD","SG9999014880.SGD","LU0786609619.USD","LU0889565916.HKD","BK4533","LU2168563687.JPY","LU2468319806.SGD","LU0323591593.USD","LU2028103732.USD","LU2089984988.USD","LU0640476718.USD","LU1035775433.USD","IE00BJJMRY28.SGD","IE0009355771.USD","LU0823434740.USD","LU0820561818.USD","IE00BFSS8Q28.SGD","LU2108987350.USD","LU2324357040.USD","LU0820562030.AUD","IE00B1XK9C88.USD","SG9999014914.USD","LU2750360997.AUD","LU2237443465.HKD","LU0823416689.USD","LU2112291526.USD","LU0122379950.USD","LU2023251221.USD","LU2361044949.HKD","IE00BKDWB100.SGD","BK4581","LU0823434583.USD","SG9999015978.USD","LU0943347566.SGD","LU2361045086.USD","LU0158827781.USD","LU0198837287.USD","LU1917777945.USD","BK4007","LU2023250504.SGD","LU1868836591.USD","LU2237438978.USD","SGXZ57979304.SGD","LU0672654240.SGD","IE00BKPKM429.USD","LU0353189763.USD","BK7508","LU1127390331.HKD","SG9999015945.SGD","LU0109394709.USD","LU0256863902.USD","LU0210536198.USD","LU1280957306.USD","LU2756315318.SGD","BK4516","LU0820561909.HKD","LU2213496289.HKD","SG9999014898.SGD","BK7501","LU2491050071.SGD","LU2236285917.USD","LU2361044865.SGD","SGXZ51526630.SGD","BK7511","LU2237443382.USD","SG9999013999.USD","LU2491049909.HKD","LU2265009873.SGD","LU0432979614.USD","LU1868837136.USD","LU2087625088.SGD","SG9999015986.USD","LU0316494557.USD","LU0238689110.USD","LU2168564222.USD","LU1548497426.USD","LU0256863811.USD","SG9999001176.USD","LU0109391861.USD","LU1804176565.USD","BK4585","IE00BFSS7M15.SGD","LU0689472784.USD","LLYZ","LU1023059063.AUD","LU0320765992.SGD","LU1868837300.USD","LU0417517546.SGD","SG9999018865.SGD","GB00BDT5M118.USD","LU0385154629.USD","LU2168564065.EUR","IE00B775H168.HKD","LU1629891620.HKD","LU1989771016.USD","LU1093756168.USD","LU2746668461.USD","LU2746668974.SGD","LU2106854487.HKD","LU0964807845.USD","LU2461242641.AUD","LU2211815571.USD","LU2089284900.SGD","LU2471134523.USD","LU2264538146.SGD","LU1232071149.USD","LU0079474960.USD","LU0708995401.HKD","LU1069344957.HKD","LU2552382132.HKD","LU2357305700.SGD","LU1145028129.USD","IE00BJLML261.HKD","LU0882574139.USD","LU2237443549.SGD","LU1988902786.USD","LU0466842654.USD","IE0004445015.USD","IE0002141913.USD","IE00B4JS1V06.HKD","IE00BN29S564.USD","LU0225283273.USD","LU0234572021.USD","IE00B1BXHZ80.USD","LU2168564495.EUR","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","SG9999001176.SGD","IE00B4R5TH58.HKD","LU0097036916.USD","LU2237443978.SGD","LU1983299246.USD","LU2456880835.USD","SGXZ81514606.USD","IE00BK4W5L77.USD","LU1712237335.SGD","LU0882574055.USD","LU1868836914.USD","LU2750360641.GBP","LU0320765059.SGD","LU1974910355.USD","LU1551013425.SGD","BK4534","LU2552382058.USD","LU2462157665.USD","ELIL","LU0058720904.USD","SG9999018857.SGD","BK4599","LU2471134952.CNY","LU0203201768.USD","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","LLYX","LU1267930730.SGD","LU2237443622.USD","LU0354030511.USD","IE00BJJMRX11.SGD","LU0114720955.EUR","LU2089283258.USD","LU2360106947.USD","LU2417539215.USD","LU2063271972.USD","LU1623119135.USD","LU1720051017.SGD","IE00BWXC8680.SGD","LU1057294990.SGD","CSL.AU","LU2552382215.SGD","LU0683600562.USD","SGXZ99366536.SGD","LU0006306889.USD","LU2896262040.SGD","IE00B7KXQ091.USD","BK4588","LU1093756325.SGD","LU1366192091.USD","LU1720051108.HKD","LU1814569148.SGD","LU1551013342.USD","LU2602419157.SGD","IE0005OL40V9.USD","LU2111349929.HKD","ELIS","LU0096364046.USD","LLY"],"gpt_icon":1},{"id":"1120730244","title":"CSL有限公司簽署獨家許可協議 獲Clazakizumab開發及商業化特定權利","url":"https://stock-news.laohu8.com/highlight/detail?id=1120730244","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120730244?lang=zh_tw&edition=fundamental","pubTime":"2026-02-18 05:14","pubTimestamp":1771362894,"startTime":"0","endTime":"0","summary":"CSL有限公司宣布达成一项独家授权协议，获得针对Clazakizumab的特定开发及商业化权利。该协议进一步拓展了公司在创新疗法领域的战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7501","BK7067","BK7511","CSL.AU"],"gpt_icon":0},{"id":"1193258984","title":"Botanix製藥公司獲得4000萬澳元兩輪增發堅定承諾，新股發行價每股0.06澳元","url":"https://stock-news.laohu8.com/highlight/detail?id=1193258984","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193258984?lang=zh_tw&edition=fundamental","pubTime":"2026-02-17 06:44","pubTimestamp":1771281854,"startTime":"0","endTime":"0","summary":"Botanix Pharmaceuticals Ltd（澳交所代码：BOT）宣布已成功获得总额4000万澳元的两轮增发坚定认购承诺。此次增发的新股定价为每股0.06澳元，标志着市场对该公司发展前景的强劲信心。\n这项融资计划将分两个阶段实施，旨在为公司的研发项目和运营扩张提供资金支持。每股0.06澳元的发行价反映了投资者对Botanix制药业务战略和增长潜力的认可。此次增发的顺利完成，预计将显著增强公司的资金实力，为其在制药领域的持续创新和市场拓展奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BOT.AU","BK7502","BK7096"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}